Literature DB >> 11007832

Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.

P Stenvinkel1, B Lindholm, M Heimbürger, O Heimbürger.   

Abstract

BACKGROUND: Atherosclerotic cardiovascular disease, malnutrition, and increased levels of pro-inflammatory cytokines are common features in patients with chronic renal failure, and contribute to the high mortality rate observed in these patients. A diverse group of soluble cellular adhesion molecules (CAM) (sVCAM-1, sICAM-1 and sE-selectin) are expressed on the surface of vascular endothelial cells in response to pro-inflammatory cytokines and may play an important role in the atherogenic process.
METHODS: Serum levels of sVCAM-1, sICAM-1 (n=87) and sE-selectin (n=71) were analysed in a cohort of 88 patients (50+/-1 years) with chronic renal failure. The presence of malnutrition (subjective global assessment (SGA) and serum albumin), inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-alpha), and serum hyaluronan), and cardiovascular disease (CVD) were assessed at a time-point close to the start of dialysis treatment (GFR 7+/-1 ml/min). Blood lipid parameters were also assessed.
RESULTS: Significant correlations were observed between Log high-sensitivity CRP (hsCRP) and sVCAM-1 (R=0.39; P<0.01) and sICAM-1 (R=0.47; P:<0.001) levels but not between Log hsCRP and sE-selectin levels in 60 patients examined with a hsCRP assay. Also serum concentrations of Log hyaluronan correlated significantly to sVCAM-1 (R=0.34; P<0.01) and sICAM-1 (R=0.29; P<0.05) levels. Malnourished patients (SGA>1) had elevated serum concentrations of sVCAM-1 (1436+/-94 vs. 1105+/-53 ng/ml; P<0.01) compared to well-nourished patients (SGA 1). Patients with clinical signs of CVD (n=26) had elevated serum levels of sICAM-1 (282+/-18 vs. 242+/-9 ng/ml; P<0.05) compared to 61 patients without signs of CVD. Plasma Log lipoprotein (a) (Lp(a)) levels correlated significantly with sVCAM-1 (R=0.30; P<0.01). Survival analysis by the Cox regression model showed that elevated sICAM-1 was, independent of age, SGA, CVD, and Log CRP, significantly related to an increased mortality rate.
CONCLUSIONS: Elevated serum concentrations of soluble adhesion molecules are found in pre-dialysis patients who are malnourished, inflamed, and have signs of cardiovascular disease. These data also suggest that sICAM-1 is an independent predictor of mortality in pre-dialysis patients. Further studies are needed to determine if inflammation causes accelerated atherogenesis via effects on soluble adhesion molecules or if elevated serum levels of soluble adhesion molecules are merely markers of endothelial activation in patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007832     DOI: 10.1093/ndt/15.10.1624

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  41 in total

1.  Cyanate is a novel inducer of endothelial icam-1 expression.

Authors:  Dalia El-Gamal; Michael Holzer; Martin Gauster; Rudolf Schicho; Veronika Binder; Viktoria Konya; Christian Wadsack; Rufina Schuligoi; Akos Heinemann; Gunther Marsche
Journal:  Antioxid Redox Signal       Date:  2011-10-14       Impact factor: 8.401

2.  Heritability of renal function and inflammatory markers in adult male twins.

Authors:  Paolo Raggi; Shaoyong Su; Cristina Karohl; Emir Veledar; Enrique Rojas-Campos; Viola Vaccarino
Journal:  Am J Nephrol       Date:  2010-08-17       Impact factor: 3.754

3.  Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus.

Authors:  Qunying Han; Lei Zhang; Zhengwen Liu; Wen Kang; Sai Lou; Jianming Qiu; Zhu Li; Guoyu Zhang; Yawen Wang; Man Li; Na Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

4.  High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients.

Authors:  Jia-Feng Chang; Shih-Ping Hsu; Mei-Fen Pai; Ju-Yeh Yang; Hung-Yuan Chen; Hon-Yen Wu; Yu-Sen Peng
Journal:  Int Urol Nephrol       Date:  2013-04-06       Impact factor: 2.370

Review 5.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

Review 6.  Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.

Authors:  Csaba P Kovesdy; Leigh Darryl Quarles
Journal:  Nephrol Dial Transplant       Date:  2013-04-25       Impact factor: 5.992

7.  Comparison of novel risk factors for cardiovascular disease between hemodialysis patients with and without protein-energy wasting.

Authors:  Hadi Tabibi; Atefeh As'habi; Mitra Mahdavi-Mazdeh; Mehdi Hedayati; Behnaz Nozary-Heshmati
Journal:  Int Urol Nephrol       Date:  2014-06-07       Impact factor: 2.370

8.  Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.

Authors:  Jie Dong; Yan-Jun Li; Zhi-Kai Yang; Rong Xu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 9.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

10.  Statins and vitamin D: a friendly association in pre-dialysis patients.

Authors:  Pedro L Neves; Anabela Malho; Ana Cabrita; Ana Pinho; Alexandre Baptista; Elsa Morgado; Marília Faísca; Hermínio Carrasqueira; Ana P Silva
Journal:  Int Urol Nephrol       Date:  2009-09-11       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.